Summary
On 7 November, at the ninth China International Import Expo, New Zealand's a2 Milk Company,
in partnership with China State Farms Holdings Shanghai, launched three new infant formula products for the Chinese market: a2 Zhi Chu Qi Run, a2 Zhi Chu Zhi Chun and an upgraded a2 Zi Bai Jin. The upgraded a2 Zi Bai Jin features top-level DHA content,
eight times the lutein and three human milk oligosaccharide (HMO) related formulations, with packaging that uses a lock-seal lid and a separate precision measuring scoop. The a2 Zhi Chu family also expanded: a2 Zhi Chu Qi Run is a2's first dual-patent product, exploring formulation innovation around three 'maternal-type' nutritional dimensions — A2 protein,
lipids and oligosaccharides; a2 Zhi Chu Zhi Chun is a2's first organic A2 protein formula, sourced from New Zealand organic grass-fed farms and holding dual organic certification from China and New Zealand,
meeting consumer demand for both organic milk sources and scientific formulations.
Commentary
a2 Milk Company's three new infant formula products reflect a Chinese infant formula market shifting from the stock competition that followed the formula registration system towards segmented functionality and quality upgrades. As a pioneer of New Zealand A2 protein dairy products, a2 achieved rapid growth in China through differentiated positioning, but in recent years has faced pressure from local brands such as Feihe and Yili in the premium segment, as well as from international giants like Danone and Wyeth catching up in areas such as HMO and organic. Among the new products, a2 Zhi Chu Zhi Chun focuses on organic A2 protein, with milk sourced from New Zealand organic grass-fed farms and dual China-New Zealand organic certification, directly responding to Chinese consumers' dual demands for 'pure milk sources' and 'scientific formulations'.
For New Zealand small and medium-sized business owners, a2's move shows that relying solely on the 'New Zealand milk source' label is no longer enough to maintain a premium; functional ingredients or organic certification and other hard barriers must be added. At the same time, a2's choice to partner with China State Farms Holdings Shanghai, leveraging its channels and localisation capabilities, also suggests that when New Zealand brands enter the Chinese market, partnering with distributors with state-owned backgrounds can reduce policy and market risks. From a supply chain perspective, the organic milk source for a2 Zhi Chu Zhi Chun requires farms to have no chemical inputs for at least three years; New Zealand's organic farm resources are limited, which may push up the procurement cost of organic milk in the future, and small and medium-sized dairy companies need to plan ahead or seek differentiated alternatives.
In addition, China's new national standards for infant formula set stricter requirements on nutrient content; the upgraded a2 Zi Bai Jin emphasises top-level DHA, eight times the lutein and three types of HMO, showing that formulation competition has entered an 'arms race of ingredients', and New Zealand companies will find it difficult to establish a foothold in the premium market without R&D investment. a2's continued innovation consolidates its leadership in China's A2 segment, but whether it can open new growth space through an organic product line depends on Chinese consumers' willingness to pay for organic infant formula and its ability to penetrate lower-tier channels.
Keywords: a2 Milk Company, new infant formula products, China International Import Expo, a2 Zi Bai Jin, a2 Zhi Chu Qi Run, a2 Zhi Chu Zhi Chun, China State Farms Holdings Shanghai, A2 protein, organic certification
AI illustration on MiDeer Observer
Source: Sharemarket Forum
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.





